Opko Health (OPK) Short-term Investments (2011 - 2018)

Opko Health (OPK) reported Short-term Investments of $26.3 million for Q4 2018, up 68.31% quarter-over-quarter from $15.6 million in Q2 2016.

Opko Health (OPK) Short-term Investments (2011 - 2018) Analysis & Trends

Opko Health has reported Short-term Investments for 5 years, with the latest figure at $26.3 million in Q4 2018.

For the quarter ending Q4 2018, Short-term Investments changed N/A year-over-year to $26.3 million; the trailing twelve-month figure through Dec 2018 stood at $26.3 million (changed N/A YoY), and the FY2018 full-year result was $26.3 million, changed N/A from the prior year.
Short-term Investments for Q4 2018 stood at $26.3 million, up from $15.6 million in the prior quarter.
The five-year high for Short-term Investments was $26.3 million in Q4 2018, with the low at $15.6 million in Q2 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	30,529.42 Bn	30,528.96 Bn	1.11 Bn
2	Thermo Fisher Scientific	183.75 Bn	180.50 Bn	7.74 Bn
3	Danaher	133.13 Bn	127.43 Bn	3.59 Bn
4	Idexx Laboratories	46.14 Bn	45.94 Bn	722.74 Mn
5	Agilent Technologies	38.20 Bn	36.39 Bn	990.00 Mn
6	Natera	31.50 Bn	30.40 Bn	696.04 Mn
7	Iqvia Holdings	31.34 Bn	29.36 Bn	1.36 Bn
8	Illumina	24.51 Bn	23.36 Bn	721.00 Mn
9	Mettler Toledo International	23.53 Bn	23.47 Bn	555.82 Mn
10	Opko Health	1.09 Bn	747.11 Mn	45.76 Mn

Download Data